Papilloma of buccal mucosa

Summary

Papilloma of buccal mucosa (MONDO:0021276) is a disease. A subtype of papilloma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	papilloma of buccal mucosa
Mondo ID	MONDO:0021276
NCIT	C5819
SNOMED CT	448147005
UMLS	C1332641
MedGen	231971
Anatomy (UBERON)	UBERON:0006956
Is cancer (heuristic)	no

Also known as: buccal mucosa papilloma · papilloma of the buccal mucosa

Disease family

This is a subtype of papilloma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › epithelial neoplasm › papillary epithelial neoplasm › papilloma › papilloma of buccal mucosa

Related subtypes (13): squamous papilloma, intraductal papilloma, serous surface papilloma, fallopian tube papilloma, verrucous papilloma, skin papilloma, inverted papilloma, cervical mullerian papilloma, transitional cell papilloma, lung papilloma, choroid plexus papilloma, glandular papilloma, laryngeal papillomatosis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.